Literature DB >> 9971916

Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships.

M T Cronin1, J C Dearden, G P Moss, G Murray-Dickson.   

Abstract

Permeability coefficients for 114 compounds across excised human skin in vitro were taken from Kirchner et al. Forty-seven descriptors were calculated encompassing the relevant physicochemical parameters of the compounds. Quantitative structure-permeability relationships (QSPRs) were developed using least-squares regression analysis. A two-parameter QSPR, describing the permeability coefficients (Kp) across excised skin, was obtained: log Kp=0.772 log P -0.0103 Mr - 2.33 where log P is the logarithm of the octanol-water partition coefficient and Mr is molecular mass. This equation indicates that percutaneous absorption is mediated by the hydrophobicity and the molecular size of the penetrant. Comparison with a QSPR based on penetration across a synthetic (polydimethylsiloxane) membrane suggests that the mechanisms of drug flux across polydimethylsiloxane membranes and excised human skin are significantly different.

Entities:  

Mesh:

Year:  1999        PMID: 9971916     DOI: 10.1016/s0928-0987(98)00041-4

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  22 in total

1.  Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation.

Authors:  Sandrine Geinoz; Richard H Guy; Bernard Testa; Pierre-Alain Carrupt
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Toward better QSAR/QSPR modeling: simultaneous outlier detection and variable selection using distribution of model features.

Authors:  Dongsheng Cao; Yizeng Liang; Qingsong Xu; Yifeng Yun; Hongdong Li
Journal:  J Comput Aided Mol Des       Date:  2010-11-13       Impact factor: 3.686

3.  In silico prediction of drug permeability across buccal mucosa.

Authors:  Amit Kokate; Xiaoling Li; Paul J Williams; Parminder Singh; Bhaskara R Jasti
Journal:  Pharm Res       Date:  2009-01-30       Impact factor: 4.200

4.  The effect of topical anal captopril on resting anal pressure in healthy volunteers: the first human pilot study.

Authors:  M Khaikin; B Bashankaev; D Sands; E G Weiss; A Zbar; S D Wexner
Journal:  Tech Coloproctol       Date:  2013-02-22       Impact factor: 3.781

5.  Modeling and Prediction of Solvent Effect on Human Skin Permeability using Support Vector Regression and Random Forest.

Authors:  Hiromi Baba; Jun-ichi Takahara; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2015-06-02       Impact factor: 4.200

6.  Evaluation on the reliability of the permeability coefficient (Kp) to assess the percutaneous penetration property of chemicals on the basis of Flynn's dataset.

Authors:  Carolin Kladt; Kathrin Dennerlein; Thomas Göen; Hans Drexler; Gintautas Korinth
Journal:  Int Arch Occup Environ Health       Date:  2018-02-21       Impact factor: 3.015

7.  Quantitative structure-permeation relationships for solute transport across silicone membranes.

Authors:  Sandrine Geinoz; Sebastien Rey; Gilles Boss; Annette L Bunge; Richard H Guy; Pierre-Alain Carrupt; Marianne Reist; Bernard Testa
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

8.  Nonlinear quantitative structure-property relationship modeling of skin permeation coefficient.

Authors:  Brian J Neely; Sundararajan V Madihally; Robert L Robinson; Khaled A M Gasem
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

9.  The Effect of Particle Size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: A Histological Study.

Authors:  Zahra Mardhiah Adib; Saeed Ghanbarzadeh; Maryam Kouhsoltani; Ahmad Yari Khosroshahi; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-03-17

Review 10.  Percutaneous permeation enhancement by terpenes: mechanistic view.

Authors:  Bharti Sapra; Subheet Jain; A K Tiwary
Journal:  AAPS J       Date:  2008-02-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.